whitepaper

Whitepaper: SARS-CoV-2 Omicron spike protein and antibodies available

Posted: 21 December 2021 | | No comments yet

Sino Biological has developed recombinant Omicron Spike RBD protein and antibody reacting with Omicron to support the study of Omicron variant.

Sino Biological has developed recombinant Omicron Spike RBD protein and antibody reacting with Omicron to support the study of Omicron variant. More Omicron antigens, including B.1.1.529 S-ECD, S1, and Nucleocapsid, are coming soon.












    To read this whitepaper in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Sino Biological

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.